we ensure early and non-invasive detection of critical conditions such as stroke and hypertension. Clinical trials across Thailand validate our commitment to accuracy, quality, and continuous improvement in healthcare delivery
SKAI-Touch by SKAI MED integrates advanced piezoelectric ceramics and machine-learning algorithms to transform arterial pulses into actionable signals.
Led by a multidisciplinary team of engineers, physicians, and clinical researchers, SKAI MED is driven by decades of expertise in nuclear engineering, preventive care, and biosensor innovation.
SKAI MED is at the forefront of health technology, leveraging piezoelectric sensors and AI-driven pulse wave analysis to deliver non-invasive, accessible, and highly accurate cardiovascular diagnostics. Our flagship product, SKAI-Touch, is a game-changer in stroke prevention and blood pressure monitoring—two of the most pressing challenges in global healthcare.
The revolution in healthcare is driven by the integration of artificial intelligence (AI) and real-time monitoring technologies, addressing the needs of an increasingly super-aged society, and a shift towards prevention and personalized care.
Heart disease and strokes are leading causes of death worldwide, often due to undetected risks like narrowed arteries or high blood pressure. SKAI MED uses innovative technology to catch these issues early, helping you stay healthy without invasive procedures.
Preventing Strokes - Strokes affect 15 million people annually, often due to carotid artery stenosis caused by cholesterol, smoking, or diabetes. SKAI-Touch detects blockages early with a 30-second neck scan, preventing up to 80% of stenosis-related strokes.
Managing Hypertension - Hypertension impacts 1.28 billion adults, increasing heart attack and stroke risks. SKAI-Touch offers continuous, cuffless monitoring, ideal for hospitals and wearables, with >85% accuracy vs. invasive methods.
It’s like a digital stethoscope, using sensitive sensors to “listen” to your arteries. AI analyzes the data to spot risks in seconds, all without needles or costly equipment.
Anyone over 50, or with high cholesterol, diabetes, smoking habits, or stress, faces higher risks. SKAI-Touch makes screening accessible to all.
SKAI-Touch streamlines diagnostics, cutting costs by 70% and improving patient outcomes. Hospitals can screen more patients for stroke risk or monitor blood pressure during surgeries without invasive methods. It’s a win-win: better care, lower expenses, and happier patients.
Starting with Thailand’s 15 million at-risk adults, SKAI-Touch aims to reach billions worldwide. By preventing strokes and managing hypertension, we could save millions of lives and save healthcare systems billions annually. Our global licensing and wearable tech plans make this vision a reality.
